Expression vector of human SMAD2.
Alternative name | SET-0209_1-1 |
---|---|
Clone info. | Expression vector of human SMAD2. Expression has not yet been confirmed. |
Comment | Derived from Sugano CAS09876. PCR cloning, forward primer: atgtcgtccatcttgccattcacg; reverse primer: ttatgacatgcttgagcaacgcact. cDNA fragment 293 to 1696nt of NM_005901.5 (cds 293-1696nt) was cloned. Known difference: T to C substitution at 583nt (silent). |
Vector backbone | pCMV_S-FLAG (RDB05956) (Plasmid) |
Size of vector backbone | 5.5 kb |
Selectable markers | Amp^r (E. coli), Neo^r (mammalian cell) |
Growth conditions | 37C, LB+Amp |
Gene/insert name | Human MADH2/SMAD2 cDNA |
Depositor|Developer | DNA Bank, | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() MTA, for use for for-profit purpose [Word ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | The RECIPIENT agrees to describe RIKEN BRC as the source of the MATERIAL and cite Gene 200, 149-156, 1997 in any publication. Additional terms and conditions: Regrding pRc/CMV: a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only. b) LIFE MATERIALS shall not be used for any commercial purposes. c) LIFE MATERIALS shall not be transferred beyond the specified recipient. d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 提供同意書 (MTA, 営利目的用)[Word ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 発表に際し、理研BRCから入手したことを明記し、指定する文献(Gene, 200, 149-156 (1997))を引用すること。 付加的使用条件: pRc/CMVについて: a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only. b) LIFE MATERIALS shall not be used for any commercial purposes. c) LIFE MATERIALS shall not be transferred beyond the specified recipient. d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above. |
Catalog # | Resource name | Shipping form | Fee |
---|---|---|---|
RDB07000 | pCMFlag_hsSMAD2 | DNA solution |
JPY 9,460 (not-for-profit academic purpose) JPY 18,920 (for-profit-research purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pCMFlag_hsSMAD2 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07000). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB14573_A7B6p1.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CMV-Forward Sequence file: RDB14573_A7B6a.seq ![]() |
---|
>07000_14573_A7B6_CMV-Forward_A11_02_ABI24.ab1 1 CTGTCACTCC GCCCATTGAC GCAATGGGCG GTAGGCGTGT ACGGTGGGAG GTCTATATAA 61 GCAGAGCTCT CTGGCTAACT AGAGAACCCA CTGCTTACTG GCTTATCGAA ATTAATACGA 121 CTCACTATAG GGAGACCCAA GCTGAATTCA CCATGGACTA CAAGGACGAT GACGATAAGG 181 CGGCCATGTC GTCCATCTTG CCATTCACGC CGCCAGTTGT GAAGAGACTG CTGGGATGGA 241 AGAAGTCAGC TGGTGGGTCT GGAGGAGCAG GCGGAGGAGA GCAGAATGGG CAGGAAGAAA 301 AGTGGTGTGA GAAAGCAGTG AAAAGTCTGG TGAAGAAGCT AAAGAAAACA GGACGATTAG 361 ATGAGCTTGA GAAAGCCATC ACCACTCAAA ACTGTAATAC TAAATGTGTT ACCATACCAA 421 GCACTTGCTC TGAAATTTGG GGACTGAGTA CACCAAATAC GATAGATCAG TGGGACACAA 481 CAGGCCTTTA CAGCTTCTCT GAACAAACCA GGTCTCTTGA TGGTCGTCTC CAGGTATCCC 541 ATCGAAAAGG ATTGCCACAT GTTATATATT GCCGATTATG GCGCTGGCCT GATCTTCACA 601 GTCATCATGA ACTCAAGGCA ATTGAAAACT GCGAATATGC TTTTAATCTT AAAAAGGATG 661 AAGTATGTGT AAACCCTTAC CACTATCAGA GAGTTGAGAC ACCAGTTTTG CCTCCAGTAT 721 TAGTGCCCCG ACACACCGAG ATCCTAACAG AACTTCCGCC TCTGGATGAC TATACTCACT 781 CCATTCCAGA AAACACTAAC TTCCCAGCAG GAATTGAGCC ACAGAGTAAT TATATTCCAG 841 AAACGCCACC TCCTGGATAT ATCAGTGAAG ATGGAGAAAC AAGTGACCAA CAGTTGAATC 901 AAAGTATGGA CACAGGCTCT CCAGCAGAAC TATCTCCTAC TACTCTTTCC CCTGTTAATC 961 ATAGCTTGGA TTTACAGCCC AGTTTACTTA CTCAGACCTG CATTTTGGTG TTCGATAGCA 1021 TATTATGATT TAAATCAGAG GTTGGGAGAA ACCTTTCATG CATCACAGCC CTCCACTTCA 1081 CTGTAGATTG CCTTTACGGA CCATTCCAAA ATTCAAGAAG AAAGGATTC // |
Primer: BGH_rev2 Sequence file: RDB14573_A7B6b.seq ![]() |
>07000_14573_A7B6_BGH_rev2_B11_05_ABI24.ab1 1 CGTTTCGCGC TCAGGACGCA CGGGGGAGGG GCAACAACAG ATGGCTGGCA ACTAGAAGGC 61 ACAGTCGAGG CTGATCAGCG AGCTCTAGCA TTTAGGTGAC ACTATAGAAT AGGGCCCTCT 121 AGATGCATGC TCGAGCGGCC TTATGACATG CTTGAGCAAC GCACTGAAGG GGATCCCATC 181 TGAGTTAATA CTTTGTCCAA CCACTGTAGA GGTCCATTCA GATGAAGTTC AATCCAGCAA 241 GGAGTACTTG TTACCGTCTG CCTTCGGTAT TCTGCTCCCC ACCCTTTCAC AAAACTCATT 301 CTTATGGTGC ACATTCTAGT TAGCTGATAG ACGGCTTCAA AACCCTGATT AACAGACTGA 361 GCCAGAAGAG CAGCAAATTC CTGGTTGTTG AAGATCTTCA GATTACAGCC TGGTGGAATT 421 TTACACACTG TTGCAGGGTG CCAGCCATAT CTCTGATTAC AATTGGGGCT CTGCACAAAG 481 ATTGCACTAT CACTTAGGCA CTCAGCAAAA ACTTCCCCAC CTATGTAGTA TAAGCGCACT 541 CCTCTTCCTA TATGCCTTCT TGTCATTTCT ACCGTGGCAT TTCGGTTAAC ATTGGAGAGT 601 AAACCTAAGC AGAACCTCTC TGAATTTGAT GGGTCTGTAA AGCCATCTAC AGTGAGTGAG 661 GGCTGTGATG CATGGAAGGT TTCTCCAACC CTCTGATTTA ATTCATAATA TGCTATCGAA 721 CACCAAAATG CAGGTTCTGA GTAAGTAACT GGCTGTAAAT CCAAGCTATG ATTAACAGGG 781 GAAAGAGTAG TAGGAGATAG TTCTGCTGGA GAGCCTGTGT CCATACTTTG ATTCAACTGT 841 TGGTCACTTG TTTCTCCATC TTCACTGATA TATCCAGGAG GTGGCGTTTC TGGAATATAA 901 TTACTCTGTG GCTCAATTTC CTGCTGGGAA GTTAGTGTTT TTCTGGAATG GGAGTGAGTA 961 TAGTCATCCA GAGGCCGGAA GTTTCTGTTA GAATCTCCGG TGTGTCGGGG CACTTAATAC 1021 TGGAGGCAAA ACTTGCTGTC CTCACTCCTC TGATAGTGGG TTAGGGCTTA CGCATACCGT 1081 TCAATCCCTT TTTTAGGATG AAAGCACATA TCGCCCAGGC TTTTCCAGAG TTGCCTTTGT 1141 GAGG // |
Primer: SV40pro_F_V2 Sequence file: RDB14573_A7B6c.seq ![]() |
>07000_14573-A7B6_SV40proF_V2_E04_13_ABI24.ab1 1 GGACCAAGCT TTTTTGGAGG GCTAGGCTTT TGCAAAAGCT CCCGGGAGCT TGGATATCCA 61 TTTTCGGATC TGATCAAGAG ACAGGATGAG GATCGTTTCG CATGATTGAA CAAGATGGAT 121 TGCACGCAGG TTCTCCGGCC GCTTGGGTGG AGAGGCTATT CGGCTATGAC TGGGCACAAC 181 AGACAATCGG CTGCTCTGAT GCCGCCGTGT TCCGGCTGTC AGCGCAGGGG CGCCCGGTTC 241 TTTTTGTCAA GACCGACCTG TCCGGTGCCC TGAATGAACT GCAGGACGAG GCAGCGCGGC 301 TATCGTGGCT GGCCACGACG GGCGTTCCTT GCGCAGCTGT GCTCGACGTT GTCACTGAAG 361 CGGGAAGGGA CTGGCTGCTA TTGGGCGAAG TGCCGGGGCA GGATCTCCTG TCATCTCACC 421 TTGCTCCTGC CGAGAAAGTA TCCATCATGG CTGATGCAAT GCGGCGGCTG CATACGCTTG 481 ATCCGGCTAC CTGCCCATTC GACCACCAAG CGAAACATCG CATCGAGCGA GCACGTACTC 541 GGATGGAAGC CGGTCTTGTC GATCAGGATG ATCTGGACGA AGAGCATCAG GGGCTCGCGC 601 CAGCCGAACT GTTCGCCAGG CTCAAGGCGC GCATGCCCGA CGGCGAGGAT CTCGTCGTGA 661 CCCATGGCGA TGCCTGCTTG CCGAATATCA TGGTGGAAAA TGGCCGCTTT TCTGGATTCA 721 TCGACTGTGG CCGGCTGGGT GTGGCGGACC GCTATCAGGA CATAGCGTTG GCTACCCGTG 781 ATATTGCTGA AGAGCTTGGC GGCGAATGGG CTGACCGCTT CCTCGTGCTT TACGGTATCG 841 CCGCTCCCGA TTCGCAGCGC ATCGCCTTCT ATCGCCTTCT TGACGAGTTC TTCTGAGCGG 901 GACTCTGGGG GTTCGAAATG ACCGACCCAA GCGACGCCCA ACCCTGCCCA TCACGAGATT 961 TCGATTCCAC CGCCCGCCTT TCTATGAAAG GTTGGGCTTC GGAATCGTTT TCCGGACGCC 1021 GGCTGGATGA TCCTCAGCGC GGGATCTCAT GCCTGAGTCC TCGGCCAACC CCAACTGTAA 1081 TGGCAGCTTA ATATGTACAA ATTAAGGCAA TATAAGGC // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content